ZO-Y49 PhaseIII clinical trial
Phase 3
- Conditions
- Gynecologic Disease
- Registration Number
- JPRN-jRCT2080220729
- Lead Sponsor
- ZERIA Pharmaceutical Co.,Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
Out patients who can understand the content of this trial and from whom a written informed consent to participate in this study can be directly obtained.
In addition, in the case of patients whose age is less than 20 years old when the informed consent is obtained, the patients from whose representative a written informed consent must be obtained too.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety, Efficacy
- Secondary Outcome Measures
Name Time Method